Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Redburn Partners Initiates Coverage On PepsiCo with Sell Rating

Redburn Partners Initiates Coverage On PepsiCo with Sell Rating

Redburn Partners analyst Charlie Higgs initiates coverage on PepsiCo (NASDAQ:PEP) with a Sell rating.

byBenzinga Newsdesk

November 4, 2022

1 minute read

Redburn Partners analyst Charlie Higgs initiates coverage on PepsiCo (NASDAQ:PEP) with a Sell rating.

Goldman Sachs Maintains Buy on Beauty Health, Lowers Price Target to $22

By Benzinga Newsdesk

August 16, 8:53 AM

Goldman Sachs analyst Amit Hazan maintains Beauty Health (NASDAQ:SKIN) with a Buy and lowers the price target from $25 to $22.

SKIN

Credit Suisse Maintains Hold on Marriott Intl, Raises Price Target to $205

By Benzinga Newsdesk

February 16, 8:47 AM

Credit Suisse analyst Patrick Scholes maintains Marriott Intl (NASDAQ:MAR) with a Hold and raises the price target from $185 to $205.

MAR

Morgan Stanley Maintains Equal-Weight on Simply Good Foods, Lowers Price Target to $39

By Benzinga Newsdesk

July 1, 9:17 AM

Morgan Stanley analyst Pam Kaufman maintains Simply Good Foods (NASDAQ:SMPL) with a Equal-Weight and lowers the price target from $41 to $39.

SMPL

Why Kintara Therapeutics Stock Is Down 70% Tuesday

By Henry Khederian

October 31, 9:20 AM

Kintara Therapeutics Inc (NASDAQ: KTRA) shares are trading lower by 69.2% to $1.16 Tuesday morning. The company has announced that their drug VAL-083 did not outperform existing treatments for glioblastoma, a severe brain cancer.

KTRA

Redburn Partners Initiates Coverage On PepsiCo with Sell Rating

Related Posts

Goldman Sachs Maintains Buy on Beauty Health, Lowers Price Target to $22

Credit Suisse Maintains Hold on Marriott Intl, Raises Price Target to $205

Morgan Stanley Maintains Equal-Weight on Simply Good Foods, Lowers Price Target to $39

Why Kintara Therapeutics Stock Is Down 70% Tuesday